BET Inhibition Enhances Chemotherapy-Induced Antitumor Immunity by Limiting Macrophage Recruitment in Triple-Negative Breast Cancer
Year: 2026
Type: preprint
Abstract: Background Chemotherapy can promote antitumor immunity in part by inducing immunogenic forms of tumor cell death, providing a rationale for combining cytotoxic agents with immunomodulatory therapies. However, chemotherapy-treated tumors may also develop myeloid-dominated microenvironments that restrict effective T cell responses. Here, we investigated whether bromodomain and extraterminal domain inhibition (BETi) could improve the immune response elicited by liposomal doxorubicin (Doxil) in triple-negative breast cancer (TNBC). Methods We evaluated JQ1 combined with Doxil in orthotopic 4T1 and EMT6 TNBC models, with other BET inhibitors and cisplatin used to examine broader applicability. Transcriptomic profiling, flow cytometry, immunofluorescence, and molecular assays characterized immune responses. T cell depletion, nude mice, and tumor rechallenge assessed immune dependence and memory. Macrophage recruitment was investigated using tumor profiling and in vitro migration assays. Results JQ1 enhanced Doxil-mediated tumor control in both models, prolonged survival in 4T1 mice, and induced complete, recurrence-free regression in EMT6 mice following repeated treatment. Additional BET inhibitors also enhanced chemotherapy efficacy. Antitumor benefit was lost in nude mice and attenuated by CD8 + T cell depletion. Combination treatment increased intratumoral T cell infiltration and activation, effector memory responses, granzyme B expression, and tumor apoptosis, while conferring resistance to rechallenge. JQ1 can reduce chemotherapy-associated macrophage accumulation, decreased CD206 and increased CD86 expression, and inhibited macrophage migration toward CCL2 and chemotherapy-treated tumor cells. Conclusions These findings suggest that BETi can improve chemotherapy-induced antitumor immunity by limiting macrophage recruitment and thereby creating a tumor microenvironment more permissive for CD8 + T cell-mediated tumor control.
Source: Research Square
Institutions: Sun Yat-sen University, Sun Yat-sen Memorial Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G3334745956, G6646150935
OpenAlex ID: W7225908146
